Excessive sympathetic activation in heart failure with obesity and metabolic syndrome

Characteristics and mechanisms

Guido Grassi, Gino Seravalle, Fosca Quarti-Trevano, Francesco Scopelliti, Raffaella Dell'Oro, Gianbattista Bolla, Giuseppe Mancia

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Congestive heart failure is characterized by sympathetic activation, which has also been described in the metabolic syndrome. No information exists, however, as to whether the sympathostimulating effects of these 2 conditions summate when heart failure is complicated by the metabolic syndrome, leading to an exceedingly high adrenergic drive. This is clinically relevant, because in heart failure sympathetic activation is closely related to mortality. We studied 48 control subjects (age: 58.4±1.6 years, mean±SEM) and 89 age-matched heart failure patients (New York Heart Association class II), of whom 47 were without and 42 were with metabolic syndrome. Measurements included blood pressure (Finapres), heart rate (ECG), and sympathetic nerve traffic (microneurography) at rest and during baroreceptor manipulation. Waist circumference, blood pressure, and metabolic variables were greater in heart failure with metabolic syndrome than in heart failure without metabolic syndrome and in control subjects. Left ventricular ejection fraction and end-diastolic diameter were similarly altered in the 2 heart failure groups. Compared with control subjects, sympathetic nerve activity was greater in heart failure patients without metabolic syndrome (64.7±3.2 versus 45.8±2.9 bursts/100 heartbeats; P

Original languageEnglish
Pages (from-to)535-541
Number of pages7
JournalHypertension
Volume49
Issue number3
DOIs
Publication statusPublished - Mar 2007

Fingerprint

Heart Failure
Obesity
Blood Pressure
Pressoreceptors
Waist Circumference
Stroke Volume
Adrenergic Agents
Electrocardiography
Heart Rate
Mortality

Keywords

  • Baroreflex
  • Heart failure
  • Metabolic syndrome
  • Sympathetic nervous system

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Excessive sympathetic activation in heart failure with obesity and metabolic syndrome : Characteristics and mechanisms. / Grassi, Guido; Seravalle, Gino; Quarti-Trevano, Fosca; Scopelliti, Francesco; Dell'Oro, Raffaella; Bolla, Gianbattista; Mancia, Giuseppe.

In: Hypertension, Vol. 49, No. 3, 03.2007, p. 535-541.

Research output: Contribution to journalArticle

Grassi, Guido ; Seravalle, Gino ; Quarti-Trevano, Fosca ; Scopelliti, Francesco ; Dell'Oro, Raffaella ; Bolla, Gianbattista ; Mancia, Giuseppe. / Excessive sympathetic activation in heart failure with obesity and metabolic syndrome : Characteristics and mechanisms. In: Hypertension. 2007 ; Vol. 49, No. 3. pp. 535-541.
@article{d33426bb348842e68cfa20631bdecf9d,
title = "Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms",
abstract = "Congestive heart failure is characterized by sympathetic activation, which has also been described in the metabolic syndrome. No information exists, however, as to whether the sympathostimulating effects of these 2 conditions summate when heart failure is complicated by the metabolic syndrome, leading to an exceedingly high adrenergic drive. This is clinically relevant, because in heart failure sympathetic activation is closely related to mortality. We studied 48 control subjects (age: 58.4±1.6 years, mean±SEM) and 89 age-matched heart failure patients (New York Heart Association class II), of whom 47 were without and 42 were with metabolic syndrome. Measurements included blood pressure (Finapres), heart rate (ECG), and sympathetic nerve traffic (microneurography) at rest and during baroreceptor manipulation. Waist circumference, blood pressure, and metabolic variables were greater in heart failure with metabolic syndrome than in heart failure without metabolic syndrome and in control subjects. Left ventricular ejection fraction and end-diastolic diameter were similarly altered in the 2 heart failure groups. Compared with control subjects, sympathetic nerve activity was greater in heart failure patients without metabolic syndrome (64.7±3.2 versus 45.8±2.9 bursts/100 heartbeats; P",
keywords = "Baroreflex, Heart failure, Metabolic syndrome, Sympathetic nervous system",
author = "Guido Grassi and Gino Seravalle and Fosca Quarti-Trevano and Francesco Scopelliti and Raffaella Dell'Oro and Gianbattista Bolla and Giuseppe Mancia",
year = "2007",
month = "3",
doi = "10.1161/01.HYP.0000255983.32896.b9",
language = "English",
volume = "49",
pages = "535--541",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Excessive sympathetic activation in heart failure with obesity and metabolic syndrome

T2 - Characteristics and mechanisms

AU - Grassi, Guido

AU - Seravalle, Gino

AU - Quarti-Trevano, Fosca

AU - Scopelliti, Francesco

AU - Dell'Oro, Raffaella

AU - Bolla, Gianbattista

AU - Mancia, Giuseppe

PY - 2007/3

Y1 - 2007/3

N2 - Congestive heart failure is characterized by sympathetic activation, which has also been described in the metabolic syndrome. No information exists, however, as to whether the sympathostimulating effects of these 2 conditions summate when heart failure is complicated by the metabolic syndrome, leading to an exceedingly high adrenergic drive. This is clinically relevant, because in heart failure sympathetic activation is closely related to mortality. We studied 48 control subjects (age: 58.4±1.6 years, mean±SEM) and 89 age-matched heart failure patients (New York Heart Association class II), of whom 47 were without and 42 were with metabolic syndrome. Measurements included blood pressure (Finapres), heart rate (ECG), and sympathetic nerve traffic (microneurography) at rest and during baroreceptor manipulation. Waist circumference, blood pressure, and metabolic variables were greater in heart failure with metabolic syndrome than in heart failure without metabolic syndrome and in control subjects. Left ventricular ejection fraction and end-diastolic diameter were similarly altered in the 2 heart failure groups. Compared with control subjects, sympathetic nerve activity was greater in heart failure patients without metabolic syndrome (64.7±3.2 versus 45.8±2.9 bursts/100 heartbeats; P

AB - Congestive heart failure is characterized by sympathetic activation, which has also been described in the metabolic syndrome. No information exists, however, as to whether the sympathostimulating effects of these 2 conditions summate when heart failure is complicated by the metabolic syndrome, leading to an exceedingly high adrenergic drive. This is clinically relevant, because in heart failure sympathetic activation is closely related to mortality. We studied 48 control subjects (age: 58.4±1.6 years, mean±SEM) and 89 age-matched heart failure patients (New York Heart Association class II), of whom 47 were without and 42 were with metabolic syndrome. Measurements included blood pressure (Finapres), heart rate (ECG), and sympathetic nerve traffic (microneurography) at rest and during baroreceptor manipulation. Waist circumference, blood pressure, and metabolic variables were greater in heart failure with metabolic syndrome than in heart failure without metabolic syndrome and in control subjects. Left ventricular ejection fraction and end-diastolic diameter were similarly altered in the 2 heart failure groups. Compared with control subjects, sympathetic nerve activity was greater in heart failure patients without metabolic syndrome (64.7±3.2 versus 45.8±2.9 bursts/100 heartbeats; P

KW - Baroreflex

KW - Heart failure

KW - Metabolic syndrome

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=33847029977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847029977&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000255983.32896.b9

DO - 10.1161/01.HYP.0000255983.32896.b9

M3 - Article

VL - 49

SP - 535

EP - 541

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 3

ER -